299 related articles for article (PubMed ID: 28138633)
1. Targeting angiogenesis in gastrointestinal tumors: current challenges.
Nandikolla AG; Rajdev L
Transl Gastroenterol Hepatol; 2016; 1():67. PubMed ID: 28138633
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies targeting vascular endothelial growth factor: current status and future challenges in cancer therapy.
Hsu JY; Wakelee HA
BioDrugs; 2009; 23(5):289-304. PubMed ID: 19754219
[TBL] [Abstract][Full Text] [Related]
3. Safety and Tolerability of Anti-Angiogenic Protein Kinase Inhibitors and Vascular-Disrupting Agents in Cancer: Focus on Gastrointestinal Malignancies.
Procaccio L; Damuzzo V; Di Sarra F; Russi A; Todino F; Dadduzio V; Bergamo F; Prete AA; Lonardi S; Prenen H; Palozzo AC; Loupakis F
Drug Saf; 2019 Feb; 42(2):159-179. PubMed ID: 30649744
[TBL] [Abstract][Full Text] [Related]
4. HER2 targeted therapy in colorectal Cancer: Current landscape and future directions.
Chen N; He L; Zou Q; Deng H
Biochem Pharmacol; 2024 May; 223():116101. PubMed ID: 38442793
[TBL] [Abstract][Full Text] [Related]
5. The role of tumor angiogenesis as a therapeutic target in colorectal cancer.
Battaglin F; Puccini A; Intini R; Schirripa M; Ferro A; Bergamo F; Lonardi S; Zagonel V; Lenz HJ; Loupakis F
Expert Rev Anticancer Ther; 2018 Mar; 18(3):251-266. PubMed ID: 29338550
[TBL] [Abstract][Full Text] [Related]
6. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
[TBL] [Abstract][Full Text] [Related]
7. Broad targeting of angiogenesis for cancer prevention and therapy.
Wang Z; Dabrosin C; Yin X; Fuster MM; Arreola A; Rathmell WK; Generali D; Nagaraju GP; El-Rayes B; Ribatti D; Chen YC; Honoki K; Fujii H; Georgakilas AG; Nowsheen S; Amedei A; Niccolai E; Amin A; Ashraf SS; Helferich B; Yang X; Guha G; Bhakta D; Ciriolo MR; Aquilano K; Chen S; Halicka D; Mohammed SI; Azmi AS; Bilsland A; Keith WN; Jensen LD
Semin Cancer Biol; 2015 Dec; 35 Suppl(Suppl):S224-S243. PubMed ID: 25600295
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers of Prognosis and Efficacy of Anti-angiogenic Therapy in Metastatic Clear Cell Renal Cancer.
D'Aniello C; Berretta M; Cavaliere C; Rossetti S; Facchini BA; Iovane G; Mollo G; Capasso M; Pepa CD; Pesce L; D'Errico D; Buonerba C; Di Lorenzo G; Pisconti S; De Vita F; Facchini G
Front Oncol; 2019; 9():1400. PubMed ID: 31921657
[TBL] [Abstract][Full Text] [Related]
9. Colonoscopy, Biomarkers, and Targeted Therapy in Colorectal Cancer.
Effendi-Ys R
Acta Med Indones; 2022 Jul; 54(3):476-486. PubMed ID: 36156476
[TBL] [Abstract][Full Text] [Related]
10. Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.
Ascierto PA; Atkins M; Bifulco C; Botti G; Cochran A; Davies M; Demaria S; Dummer R; Ferrone S; Formenti S; Gajewski TF; Garbe C; Khleif S; Kiessling R; Lo R; Lorigan P; Arthur GM; Masucci G; Melero I; Mihm M; Palmieri G; Parmiani G; Puzanov I; Romero P; Schilling B; Seliger B; Stroncek D; Taube J; Tomei S; Zarour HM; Testori A; Wang E; Galon J; Ciliberto G; Mozzillo N; Marincola FM; Thurin M
J Transl Med; 2015 Nov; 13():374. PubMed ID: 26619946
[TBL] [Abstract][Full Text] [Related]
11. [Anti-angiogenic treatments in metastatic colorectal cancer: Does a continuous angiogenic blockade make sense?].
Jary M; Borg C; Bouché O; Kim S; André T; Bennouna J
Bull Cancer; 2015 Sep; 102(9):758-71. PubMed ID: 26232849
[TBL] [Abstract][Full Text] [Related]
12. Molecular regulation of tumor angiogenesis: mechanisms and therapeutic implications.
Harper J; Moses MA
EXS; 2006; (96):223-68. PubMed ID: 16383021
[TBL] [Abstract][Full Text] [Related]
13. Anti-angiogenic Drug Resistance: Roles and Targeting of Non-coding RNAs (microRNAs and long non-coding RNAs).
Dashtaki ME; Ghasemi S
Curr Mol Pharmacol; 2023; 16(8):855-869. PubMed ID: 36475334
[TBL] [Abstract][Full Text] [Related]
14. Anti-Angiogenics: Their Value in Colorectal Cancer Therapy.
Seeber A; Gunsilius E; Gastl G; Pircher A
Oncol Res Treat; 2018; 41(4):188-193. PubMed ID: 29562227
[TBL] [Abstract][Full Text] [Related]
15. New approaches in angiogenic targeting for colorectal cancer.
Prat A; Casado E; Cortés J
World J Gastroenterol; 2007 Nov; 13(44):5857-66. PubMed ID: 17990351
[TBL] [Abstract][Full Text] [Related]
16. Expanding the Scope of Immunotherapy in Colorectal Cancer: Current Clinical Approaches and Future Directions.
Kreidieh M; Mukherji D; Temraz S; Shamseddine A
Biomed Res Int; 2020; 2020():9037217. PubMed ID: 32090113
[TBL] [Abstract][Full Text] [Related]
17. Molecular insights into clinical trials for immune checkpoint inhibitors in colorectal cancer: Unravelling challenges and future directions.
Sharma S; Singh N; Turk AA; Wan I; Guttikonda A; Dong JL; Zhang X; Opyrchal M
World J Gastroenterol; 2024 Apr; 30(13):1815-1835. PubMed ID: 38659481
[TBL] [Abstract][Full Text] [Related]
18. Systemic treatments for metastatic cutaneous melanoma.
Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
[TBL] [Abstract][Full Text] [Related]
19. Results and challenges of immune checkpoint inhibitors in colorectal cancer.
Emambux S; Tachon G; Junca A; Tougeron D
Expert Opin Biol Ther; 2018 May; 18(5):561-573. PubMed ID: 29471676
[TBL] [Abstract][Full Text] [Related]
20. Targeting angiogenesis for liver cancer: Past, present, and future.
Zhu XD; Tang ZY; Sun HC
Genes Dis; 2020 Sep; 7(3):328-335. PubMed ID: 32884987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
